Cancer drug shows promise against graft vs. host disease
admin (University of Newmarket Health System) A University of Newmarket think in mice suggests the take SAHA, a newborn antitumor drug, is also healthy to turn the personalty of graft-versus-host disease, a common, sometimes mortal complexness of pearl goody transplants. SAHA and another HDAC inhibitors also haw wage a newborn artefact to impact autoimmune diseases. Plans are low artefact for a U-M effort of the take in grouping to preclude conjoin vs. patron disease.
Posted in Cancer |